Healthcare | October 05, 2021
Amber Implants VCFix spinal system receives breakthrough designation
The first clinical trial is expected to commence in early 2022 both in Europe and the US
The first clinical trial is expected to commence in early 2022 both in Europe and the US
This positions its platform as a rapidly evolving engine for next-generation genetic medicine
New Delhi facility expands Lupin’s specialized neuro-rehabilitation network after Mumbai and Hyderabad launches
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
The medical-grade Angelas diode laser calibrated at a 1470 nm wavelength supports microsurgeries across multiple specialties
Paves way for CNS cancer test rollout
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care
Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains
Subscribe To Our Newsletter & Stay Updated
